Information About This Study:
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn’s Disease Who Have Inadequately Responded to or are Intolerant to Conventional Therapies but Have Not Failed Biologic Therapy
Study Number:
M14-433
Indication:
Crohn’s Disease
Open to Volunteers
Please call Allegiance Research Specialists to see if you qualify: 414-727-8131